These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10408622)

  • 1. Blockade of 5-hydroxytryptamine (serotonin)-2 receptors alters interleukin-1-induced changes in rat sleep.
    Imeri L; Mancia M; Opp MR
    Neuroscience; 1999; 92(2):745-9. PubMed ID: 10408622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Hydroxytryptophan, but not L-tryptophan, alters sleep and brain temperature in rats.
    Imeri L; Mancia M; Bianchi S; Opp MR
    Neuroscience; 2000; 95(2):445-52. PubMed ID: 10658624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ritanserin, a serotonin-2 receptor antagonist, improves ultradian sleep rhythmicity in young poor sleepers.
    Viola AU; Brandenberger G; Toussaint M; Bouhours P; Paul Macher J; Luthringer R
    Clin Neurophysiol; 2002 Mar; 113(3):429-34. PubMed ID: 11897543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Power spectral electroencephalogram analysis of the effects of ritanserin in freely moving rats during quiet waking.
    Moyanova S; Kirov R; Ivanova V
    Methods Find Exp Clin Pharmacol; 1997 Nov; 19(9):605-11. PubMed ID: 9500124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and long-term effects of the 5-HT2 receptor antagonist ritanserin on EEG power spectra, motor activity, and sleep: changes at the light-dark phase shift.
    Kantor S; Jakus R; Bodizs R; Halasz P; Bagdy G
    Brain Res; 2002 Jul; 943(1):105-11. PubMed ID: 12088844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muramyl dipeptide and IL-1 effects on sleep and brain temperature after inhibition of serotonin synthesis.
    Imeri L; Bianchi S; Mancia M
    Am J Physiol; 1997 Nov; 273(5):R1663-8. PubMed ID: 9374807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the serotonin 5-HT(2) antagonist, ritanserin, and the serotonin 5-HT(1A) antagonist, WAY 100635, on cocaine-seeking in rats.
    Schenk S
    Pharmacol Biochem Behav; 2000 Oct; 67(2):363-9. PubMed ID: 11124402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HT7 receptor subtype as a mediator of the serotonergic regulation of luteinizing hormone release in the zona incerta.
    Siddiqui A; Abu-Amara M; Aldairy C; Hagan JJ; Wilson C
    Eur J Pharmacol; 2004 Apr; 491(1):77-84. PubMed ID: 15102536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the 5-HT2 receptor antagonist, ritanserin on hyperthermia and depletion of 5-HT in frontal cortex induced by a 5-HT releasing drug, p-chloroamphetamine (PCA) in mice.
    Yamada J; Sugimoto Y; Ohkura M; Inoue K
    Biol Pharm Bull; 2001 Oct; 24(10):1195-7. PubMed ID: 11642332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT2 receptors are partially involved in the relationship between renin release and delta relative power.
    Brandenberger G; Luthringer R; Muller G; Gronfier C; Schaltenbrand N; Macher JP; Muzet A; Follenius M
    J Endocrinol Invest; 1996 Sep; 19(8):556-62. PubMed ID: 8905480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 5-HT2 antagonist ritanserin decreases sleep in cats.
    Sommerfelt L; Ursin R
    Sleep; 1993 Jan; 16(1):15-22. PubMed ID: 8456229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of zimeldine, a selective 5-HT reuptake inhibitor, combined with ritanserin, a selective 5-HT2 antagonist, on waking and sleep stages in rats.
    Bjorvatn B; Ursin R
    Behav Brain Res; 1990 Nov; 40(3):239-46. PubMed ID: 2149499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rat strains that differ in corticotropin-releasing hormone production exhibit different sleep-wake responses to interleukin 1.
    Opp MR; Imeri L
    Neuroendocrinology; 2001 Apr; 73(4):272-84. PubMed ID: 11340341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subchronic effects of the GABA-agonist lorazepam and the 5-HT2A/2C antagonist ritanserin on driving performance, slow wave sleep and daytime sleepiness in healthy volunteers.
    van Laar M; Volkerts E; Verbaten M
    Psychopharmacology (Berl); 2001 Mar; 154(2):189-97. PubMed ID: 11314681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of serotonergic neurotransmission in the hypnotic response to dexmedetomidine, an alpha 2-adrenoceptor agonist.
    Rabin BC; Guo TZ; Gregg K; Maze M
    Eur J Pharmacol; 1996 Jun; 306(1-3):51-9. PubMed ID: 8813614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1 induces changes in sleep, brain temperature, and serotonergic metabolism.
    Gemma C; Imeri L; de Simoni MG; Mancia M
    Am J Physiol; 1997 Feb; 272(2 Pt 2):R601-6. PubMed ID: 9124484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related effect of ritanserin on the sleep-waking phases in rats.
    Kirov R; Moyanova S
    Int J Neurosci; 1998 Apr; 93(3-4):265-78. PubMed ID: 9639244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the 5-HT2 antagonist ritanserin on sleep-walking cycle in the rat.
    Silhol S; Glin L; Gottesmann C
    Pharmacol Biochem Behav; 1992 Jan; 41(1):241-3. PubMed ID: 1539075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of 5-HT7 receptors in serotonergic effects on spike afterpotentials in presumed jaw-closing motoneurons of rats.
    Inoue T; Itoh S; Wakisaka S; Ogawa S; Saito M; Morimoto T
    Brain Res; 2002 Nov; 954(2):202-11. PubMed ID: 12414103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.